-

Global Study Measures the Impact of COVID-19 on Sleep, Fitness, Diet, and Mental Health of Pregnant People

33% Reported Elevated Mental Health Distress and Up to 45% Reported Impact on Healthy Behaviors Mainly Due to COVID-19 Physical Distancing Measures

LOS ANGELES--(BUSINESS WIRE)--A global study released today from Pregistry, a leader in the development and conduct of observational studies during pregnancy, highlights the impact of the COVID-19 pandemic on healthy behaviors during pregnancy and its association with mental health disorders. The study, conducted in 12 countries by Dr. Diego Wyszynski, Pregistry CEO, and a team of collaborators showed elevated mental health distress in one of three pregnant people and moderate impact on healthy behaviors.

Research consistently shows that COVID-19 continues to disrupt physical activity, sleep, and eating behaviors in the general population, mostly attributed to quarantine and physical distancing measures. Such reduction in healthy behaviors has been linked to worsening mental health and wellbeing. The Pregistry study, entitled COVID-19 perceived impacts on sleep, fitness, and diet and associations with mental health during pregnancy: A cross-national study, brings to light the effects of the pandemic on the pregnant population, whose mental health is particularly critical given the potential short and long-term impacts on both mother and child.

“Given the documented effects on mental health in the general population due to the COVID-19 pandemic, including depression, anxiety, and PTSD, it is critical to understand how we can support the most vulnerable populations, such as those pregnant, in this difficult time,” said Dr. Wyszynski. “Our latest work revealed a link between mental health distress and the worsening of healthy behaviors, suggesting that attention to sleep, diet, and fitness-related disruptions is important for mental health promotion during pregnancy amid a major stressor.”

In a recent survey of 3,692 pregnant people, one in three reported elevated mental health distress, and about 30-45% of the participants reported moderate to high impact on healthy behaviors across sleep, fitness, and diet. Interestingly, the impact on each healthy behavior domain (sleep, diet, fitness) was independently linked to increased mental health distress. Other results showed that a sense of community may buffer the impact of inadequate sleep and other affected healthy behaviors on mental health distress, while the opposite, loneliness, may exacerbate risks. Furthermore, the research shows that addressing sleep, diet, and fitness changes together may help prevent mental health distress in pregnancy in times of a major stressor, highlighting the importance of increasing access to support for this group during the pandemic.

Adjusting for a range of sociodemographic factors, inadequate sleep was found to be the most strongly associated with mental health distress, with pregnant people reporting the highest negative impact. Perceived COVID-19 impact on diet showed the second strongest pattern of association with mental health distress. Finally, a reported impact on fitness was also associated with elevated mental health distress, which aligns with a large base of evidence linking physical activity and mental health in the general population and during pregnancy. In the study, positive feelings of gratitude and a sense of community were found to be associated with lower reported inadequate healthy behavior. In addition, loneliness emerged as a potential risk factor for increased reports of negative impact.

Study contributors include Karmel W. Choi, Hannah H. Kim, Archana Basu, Alex S.F. Kwong, Sonia Hernandez-Diaz, Diego F. Wyszynski and Karestan C. Koenen.

About Pregistry

Pregistry is a global leader in the development and conduct of observational studies to assess the safety of medications and vaccines when used during pregnancy. With over 70 pregnancy specialists, covering a range of clinical, preclinical, safety, regulatory, marketing, and IT needs, the focus is on making sure that both mother and baby are healthy and safe and that prescribers have the information needed to be able to explain the potential benefits and risks of medications during pregnancy. Pregistry also offers pregnant people a safe space to connect with a global community of experts and peers at no cost. To learn more, please visit: https://www.pregistry.com. More Pregistry news can be found at Pregistry.com/News.

Contacts

INVESTOR CONTACT
Diego Wyszynski, MD, MHS, PhD
Chief Executive Officer
hello@pregistry.com

MEDIA CONTACT
Abigail Baker, MA
Director of Communications
press@pregistry.com

Pregistry


Release Versions

Contacts

INVESTOR CONTACT
Diego Wyszynski, MD, MHS, PhD
Chief Executive Officer
hello@pregistry.com

MEDIA CONTACT
Abigail Baker, MA
Director of Communications
press@pregistry.com

Social Media Profiles
More News From Pregistry

Dr. Cheryl Renz Joins Pregistry as Chief Medical Officer

LOS ANGELES--(BUSINESS WIRE)--Pregistry, a leader in the development and conduct of observational studies during pregnancy, announced today the appointment of Dr. Cheryl Renz as the company’s Chief Medical Officer (CMO). In this role, Dr. Renz will oversee medical and pharmacovigilance strategies for the rapidly growing maternal health organization. Dr. Cheryl Renz is an accomplished biopharmaceutical executive with expertise in clinical development, pharmacovigilance, and benefit-risk manageme...

International Pregistry Study Examines Treatments Used for COVID-19 During Pregnancy

LOS ANGELES--(BUSINESS WIRE)--In an article published this month in Pharmacoepidemiology and Drug Safety, Pregistry shares findings from its international study of treatments for COVID-19 used during pregnancy. The article titled “COVID-19 pharmacotherapy utilization patterns during pregnancy: International Registry of Coronavirus Exposure in Pregnancy (IRCEP)” is designed to guide future studies aimed at examining the safety of these treatments when used prenatally. Pregistry is a global leade...

Pregistry Shares Lessons Learned with the International Registry of Coronavirus Exposure in Pregnancy

LOS ANGELES--(BUSINESS WIRE)--In the American Journal of Epidemiology this month, Pregistry shares lessons learned during the execution of the International Registry of Coronavirus Exposure in Pregnancy (IRCEP). The article, titled “International Registry of Coronavirus Exposure in Pregnancy (IRCEP) – Cohort Description and Methodological Considerations,” identifies challenges affecting the study of COVID-19 impacts on pregnant persons, including participant retention and potential bias introdu...
Back to Newsroom